Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy
Diabetic kidney disease (DKD) is still one of the unresolved major complications of diabetes mellitus, which leads ultimately to end-stage renal disease in both type 1 and type 2 diabetes patients. Available drugs that suppress the renin-angiotensin system have partially minimized the disease impact...
Saved in:
Main Authors: | Mohamed M. El-Kady (Author), Reham A. Naggar (Author), Maha Guimei (Author), Iman M. Talaat (Author), Olfat G. Shaker (Author), Maha Saber-Ayad (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renoprotective effect of aliskiren monotherapy and aliskiren−pentoxifylline combination in hypertensive-diabetic type 2 patients with diabetic nephropathy
by: Amin T. Hamed, et al.
Published: (2013) -
Differential Renoprotective Actions of Simvastatin and Rosuvastatin in Streptozotocin-Induced Diabetes in Sprague-Dawley Rat
by: Rowaida Refaat, et al.
Published: (2020) -
Transforming growth factor-β in diabetic nephropathy
by: Karima Y. Ahmed, et al.
Published: (2013) -
Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1
by: Mariam Ali Abo-Saif, et al.
Published: (2023) -
Sensitivity and specificity of ischaemia-modified albumin in detecting diabetic nephropathy
by: Maha A.M Hussein
Published: (2018)